(Q43656929)

25 November 2017

title

Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity (English)

1 reference

25 November 2017

Hertel P

1

1 reference

25 November 2017

Byskov L

series ordinal

2

1 reference

25 November 2017

Didriksen M

series ordinal

3

1 reference

25 November 2017

Arnt J

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

422

1 reference

25 November 2017

issue

1-3

1 reference

25 November 2017

page(s)

77-81

1 reference

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Neurotensin: Antinocisponsive action in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Neurotensin blocks certain amphetamine-induced behaviours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

The effects of intra-accumbens neurotensin on sensorimotor gating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Differential neurobehavioral effects of neurotensin and structural analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

The neurobiology of neurotensin: focus on neurotensin-dopamine interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Does neurotensin mediate the effects of antipsychotic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Motor hypoactivity induced by neurotensin and related peptides in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

Highly potent neurotensin analog that causes hypothermia and antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901076-7

10.1016/S0014-2999(01)01076-7

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference